Publications
5539 Results
- Journal / Conference
- Blood Apr 1;95(7):2364-71
- Year
- 2000
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-8417/19, SWOG-9400
Cell cycle regulatory gene abnormalities are important determinants of leukemogenesis and disease biology in adult a2000 Apr 1;95(7):2364-71.cute lymphoblastic leukemia
- Journal / Conference
- Blood 95(2):398-403
- Year
- 2000
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9129 (INT-0129)
Molecular analysis and clinical outcome of adult APL patients with the type V PML-RARa isoform: results from Intergroup protocol 0129
- Journal / Conference
- Clinical Cancer Research 6:1415-1421
- Year
- 2000
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8835
Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy
- Journal / Conference
- Proc of the American Association for Cancer Research 41:611(#3885)
- Year
- 2000
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9006
Effects of leucovorin (LV) on the intratumoral (IT) pharmacokinetics (PK) of 5-fluorouracil (5-FU) - a Southwest Oncology Group study
- Journal / Conference
- Proc of the American Society of Clinical Oncology 19:194a(#754)
- Year
- 2000
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9006
Spectroscopic evaluation of intratumoral (IT) metabolic modulation (MM) of 5-fluorouracil (5-FU) by leucovorin (LV): Correlation of human tumor pharmacokinetics (PK) with modulation and tumore response. SWOG 9006
- Journal / Conference
- Proc of the American Society of Clinical Oncology 19:492a(#1923)
- Year
- 2000
- Research Committee(s)
- Lung
- Study Number(s)
- S9705
Final results from Southwest Oncology Group trial (SWOG) 9705: A phase II trial of cisplatin, etoposide, and paclitaxel (PET) with G-CSF in untreated patients (PTS) with extensive small cell lung (SCLC).
- Journal / Conference
- Proc of the American Society of Clinical Oncology 19:490a(#1916)
- Year
- 2000
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9504
Prolonged survival in pathologic stage IIIb non-small cell lung cancer (NSCLC) with concurrent chemoradiotherapy followed by consolidation docetaxel: a phase II study (S9504) of the Southwest Oncology Group (SWOG).
- Journal / Conference
- Proc of the American Society of Clinical Oncology 19:489a(#1913)
- Year
- 2000
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9509
An economic analsis of Southwest Oncology Group trial S9509: Cisplatin/vinorelbine vs. carboplatin/paclitaxel for advanced nonsmall cell lung cancer
- Journal / Conference
- Proc of the American Society of Clinical Oncology 19:411a(#1624)
- Year
- 2000
- Research Committee(s)
- Head and Neck
- Study Number(s)
- SWOG-9059 (E-1392) (INT-0126)
A phase III comparison of standard radiation thereapy (RT) versus RT plus concurrent cisplatin (DDP) versus split-course RT plus concurrent DDP and 5-Fluorouracil (5FU) in patients with unresectable squamous cell head and neck cancer (SCHNC
- Journal / Conference
- Proc of the American Society of Clinical Oncology 19:159a(#617)
- Year
- 2000
- Research Committee(s)
- Brain
- Study Number(s)
- SWOG-9310 (INT-0143) (RTOG-93-10)